Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%
NDTV Profit

The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.
Summary from NDTV Profit
Read the full story on NDTV Profit








